Effectiveness Of Individualised Homoeopathic Medicine In Females With Fibromyalgia

A Prospective Interventional Study: Effectiveness Of Individualised Homoeopathic Medicine In Females Of 30-60 Years Of Age With Fibromyalgia Assessed By Fibromyalgia Impact Questionnaire-Revised (FIQ-R) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099597

Enrollment

Registered

2025-12-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

Intervention1: Individualised Homoeopathic Medicine: Medicines Will Be Prescribed Based On The Selected Similimum From The Repertory With Each Dose Consisting Of 4 Pills Of Size No 20 Potency Selectio

Eligibility

Inclusion criteria

Inclusion criteria: Fulfilling ACR 2016 Criteria For Fibromyalgia

Exclusion criteria

Exclusion criteria: Moderate And Severe Depressive Disorder Patients Assessed By Psychiatrist Using The Hamilton Depression Rating Scale Current Use Of Corticosteroids Or Immunosuppressants Other Autoimmune Disorders Pregnant Women and Lactating Mothers

Design outcomes

Primary

Measure	Time frame
To Assess The Change In FIQ-R (Fibromyalgia Impact Questionnaire Revised) Scores After Administration Of Individualized Homoeopathic Medicine Over a Period of 6 Months In Females Aged 30-60 Years Diagnosed With FibromyalgiaTimepoint: To Assess The Change In FIQ-R (Fibromyalgia Impact Questionnaire Revised) Scores After Administration Of Individualized Homoeopathic Medicine Over a Period of 6 Months At Baseline And At 6 Month In Females Aged 30-60 Years Diagnosed With Fibromyalgia	—

Measure

Time frame

To Assess The Change In FIQ-R (Fibromyalgia Impact Questionnaire Revised) Scores After Administration Of Individualized Homoeopathic Medicine Over a Period of 6 Months In Females Aged 30-60 Years Diagnosed With FibromyalgiaTimepoint: To Assess The Change In FIQ-R (Fibromyalgia Impact Questionnaire Revised) Scores After Administration Of Individualized Homoeopathic Medicine Over a Period of 6 Months At Baseline And At 6 Month In Females Aged 30-60 Years Diagnosed With Fibromyalgia

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Jammalamadugu Damini

JIMS Homoeopathic Medical College and Hospital

vibhavya.shetty@gmail.com9391493825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026